SecBot SecBot
Insider Cluster (2 insiders) ·Filed Aug 26, 2026

TRDA

Entrada Therapeutics, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed2mo ago
Insider cluster: 2 insiders, $400K total
Actionable Insight • Neutral

The insider sales are small in magnitude and by a venture capital investor, not management. This is likely a routine portfolio reduction and does not warrant a bearish read-through. Monitor for any C-suite selling or a material increase in sales volume, which would be a stronger signal. The stock's 86% analyst bullish consensus and recent strong institutional accumulation (7 funds doubling positions) provide a counterweight.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20
Entry
$7.27
T+0 close · Aug 26, 2026 · via day close
Latest settled
−14.44%
T+20 · $6.22 · next T+60 in 3d
Vs SPY
−13.93%
α at T+20
Latest observation
+16.16%
T+55 · FF3 residual α
  1. T+0 · Aug 27 $7.27entry
  2. T+1 · 3mo ago −3.71%α −3.49% · $7.00
  3. T+5 · 3mo ago −1.38%α −1.64% · $7.17
  4. T+20 · 8w ago −14.44%α −13.93% · $6.22
  5. T+56 · todayOpen
  6. T+60 · in 3d Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two MPM BioVentures funds, each a 10% owner of Entrada Therapeutics, sold a combined ~$400K in open-market sales over three days (Aug 24-26). The total value is 0.13% of the $297M market cap, falling in the modest proportionality band. No C-suite insiders participated, and the sales are likely part of a routine portfolio reduction by a venture capital investor, not a signal of operational deterioration. The cluster is a sell, but the dollar amount is small relative to company size and lacks executive participation, limiting its informational value.

Key Financial Metrics

Direction
selling
Total Value
$400.0K
Insiders
2

Key Facts

  • Two MPM BioVentures funds (10% owners) sold a combined ~$400K in open-market sales over three days.
  • Total sales represent ~0.13% of TRDA's $297M market cap.
  • No C-suite executives (CEO, CFO, etc.) participated in the sales.
  • Sales occurred at prices between $7.06 and $7.54 per share.
  • The selling is by a venture capital investor, not company management.

Financial Impact

Total insider sales of approximately $400,000, representing 0.13% of market capitalization.

insider ownership

Risk Factors

  • Venture capital selling could continue if the funds are reducing their position over time.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (14 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-TRDA-1787794151315

Track record

21 reports on TRDA

Performance horizon

3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +58.22% at T+20 after the May 4, 2026 report. 5 of 5 went positive at some point.

Filters
  1. Nov 5, 202611d ago 8-K Neutral 4/10 No price data
  2. Nov 5, 202611d ago Press Release Neutral 4/10 Entry $4.55 Now $5.00 +9.89% settles Feb 3
  3. Oct 14, 20264w ago 8-K Bullish 6/10 Entry $4.55 Now $5.00 +9.89% settles Jan 11
  4. Sep 9, 20269w ago Insider Cluster Bearish 6/10 Entry $6.42 Now $5.00 +22.12% settles Dec 4
  5. Sep 3, 202610w ago Insider Cluster Neutral 3/10 Entry $7.13 Now $5.00 −29.87% settles Dec 1
  6. Aug 31, 202611w ago Insider Cluster Neutral 4/10 Entry $7.07 Now $5.00 −29.28% settles Nov 25
  7. Aug 31, 202611w ago Insider Cluster Neutral 4/10 Entry $7.07 Now $5.00 −29.28% settles Nov 25
  8. Aug 31, 202611w ago Insider Cluster Neutral 3/10 Entry $7.07 Now $5.00 −29.28% settles Nov 25
  9. Aug 26, 202611w ago Insider Cluster Neutral 3/10 Viewing Entry $7.27 Now $5.00 −31.22% settles Nov 20
  10. Aug 10, 202614w ago Insider Cluster Neutral 2/10 Entry $7.04 to $5.06 Now $5.00 −28.98% ▼ −28.13% −27.64% vs SPY
Showing 10 of 21

US Market Status

Market Closed · Opens in 6h 42m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 26, 2026